FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 TB 500 BLEND PEPTIDE VIAL UMBRELLA Labs BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal compounding status. Here's what's happening: After the BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health &